Related references
Note: Only part of the references are listed.Minimally Cytotoxic Doses of Temozolomide Produce Radiosensitization in Human Glioblastoma Cells Regardless of MGMT Expression
Michael S. Bobola et al.
MOLECULAR CANCER THERAPEUTICS (2010)
O-Methylguanine-DNA Methyltransferase Immunoexpression in a Double Pituitary Adenoma
Safraz Mohammed et al.
NEUROSURGERY (2010)
Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
Richard A. Feelders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Radiation therapy and stereotactic radiosurgery for the treatment of Cushing's disease: an evidence-based review
Robert M. Starke et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Pituitary carcinomas and aggressive adenomas: an overview and new therapeutic options
J. -C. Maiza et al.
ANNALES D ENDOCRINOLOGIE (2009)
O6-Methylguanine DNA Methyltransferase Immunoexpression in Nonfunctioning Pituitary Adenomas Are Progressive Tumors Potential Candidates for Temozolomide Treatment?
Georg Widhalm et al.
CANCER (2009)
Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
Ann I. McCormack et al.
CLINICAL ENDOCRINOLOGY (2009)
High incidence of low O6-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease
Akira Takeshita et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Treatment of Nelson's syndrome with temozolomide
V. J. Moyes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
C. Hagen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Effect of Temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma
Luis V. Syro et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2009)
Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
Christiaan de Bruin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
A novel use of temozolomide in a patient with malignant prolactinoma
Stephen Byrne et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
Jennifer A. Quinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
An approach to the management of patients with residual Cushing's disease
Lewis S. Blevins et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
USE OF TEMOZOLOMIDE IN AGGRESSIVE PITUITARY TUMORS: CASE REPORT
Safraz Mohammed et al.
NEUROSURGERY (2009)
Pituitary Carcinoma Presenting With Multiple Metastases: Case Report
Aslan Guzel et al.
JOURNAL OF CHILD NEUROLOGY (2008)
Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas
A. S. Aveanu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy
Kalman Kovacs et al.
ACTA NEUROPATHOLOGICA (2008)
Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists
Lisa M. Neff et al.
PITUITARY (2007)
Corticotroph tumor progression after adrenalectomy in Cushing's disease:: A reappraisal of Nelson's syndrome
Guillaume Assie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: morphological findings
Kalman Kovacs et al.
HUMAN PATHOLOGY (2007)
High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm
Luis V. Syro et al.
CLINICAL ENDOCRINOLOGY (2006)
Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas
Alexandru Saveanu et al.
NEUROENDOCRINOLOGY (2006)
Clinical review: Diagnosis and management of pituitary carcinomas
GA Kaltsas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines
MS Bobola et al.
CLINICAL CANCER RESEARCH (2005)
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide
ME Hegi et al.
CLINICAL CANCER RESEARCH (2004)
Inhibition of angiogenesis by non-toxic doses of temozolomide
H Kurzen et al.
ANTI-CANCER DRUGS (2003)
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
R Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Radiosurgery for Cushing's disease after failed transsphenoidal surgery
JM Sheehan et al.
JOURNAL OF NEUROSURGERY (2000)
Share Paper
